medigraphic.com
ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)

2024, Número S1

<< Anterior Siguiente >>

Cardiovasc Metab Sci 2024; 35 (S1)


Ovarios poliquísticos como factor de riesgo cardiometabólico para hipertensión arterial

Moreno-Ruiz LA, Madrid-Miller A, Necoechea-Osuna Y, Vega-Gutiérrez JJ

Idioma: Inglés [English version]
Referencias bibliográficas: 12
Paginas: s25-27
Archivo PDF: 168.62 Kb.





REFERENCIAS (EN ESTE ARTÍCULO)

  1. Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020; 30 (7): 399-404.

  2. Moran C, Tena G, Moran S, Ruiz P, Reyna R, Duque X. Prevalence of polycystic ovary syndrome and related disorders in Mexican women. Gynecol Obstet Invest. 2010; 69 (4): 274-280.

  3. Escobar-Morreale HF. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14 (5): 270-284.

  4. Joham AE, Boyle JA, Zoungas S, Teede HJ. Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity. Am J Hypertens. 2015; 28 (7): 847-851.

  5. Orio F, Vuolo L, Palomba S, Lombardi G, Colao A. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol. 2008; 60 (1): 39-51.

  6. Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022; 23 (2): 583.

  7. Bentley-Lewis R, Seely E, Dunaif A. Ovarian hypertension: Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2011; 40 (2): 433-449.

  8. Reckelhoff JF, Shawky NM, Romero DG, Yanes Cardozo LL. Polycystic ovary syndrome: insights from preclinical research. Kidney360. 2022; 3 (8): 1449-1457.

  9. Moulana M. Androgen-induced cardiovascular risk in polycystic ovary syndrome: the role of t lymphocytes. Life. 2023; 13 (4):1010.

  10. Norlander AE, Madhur MS, Harrison DG. The immunology of hypertension. J Exp Med. 2018; 215 (1): 21-33.

  11. Anderson S, Barry J, Hardiman P. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis. Int J Cardiol. 2014; 176 (2): 486-487.

  12. Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020; 18 (1): 23.




2020     |     www.medigraphic.com